Study guide
8.2 Assessing Specimen Suitability & Rejection Criteria
NCCT National Certified Phlebotomy Technician NCPT
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: NCPT Exam Overview, Eligibility & Study Strategy
1.1 Exam Facts, Format & Scoring 1.2 Eligibility Pathways, Application & Retake Policy 1.3 Blueprint Study Strategy & Credential Roadmap
2 Chapter 2: Infection Control & Safety (Domain 1 — 15%)
2.1 The Chain of Infection & Breaking Transmission 2.2 Hand Hygiene & Glove Use Standards 2.3 PPE Selection & Donning/Doffing Protocols 2.4 Sharps Safety & Safety-Device Activation 2.5 Isolation Precautions & Biohazard Spill Response 2.6 Cleaning & Disinfecting Equipment and Work Surfaces 2.7 OSHA Bloodborne Pathogens & Post-Exposure Management
3 Chapter 3: Equipment Selection (Domain 2A — 12 items)
3.1 Equipment Quality Verification & Allergy Alternatives 3.2 Venipuncture Equipment & Needle Anatomy 3.3 Winged Infusion Sets (Butterfly) & Syringe Systems 3.4 Capillary Equipment & Lancet Depth Selection 3.5 Bandaging Materials & Post-Collection Patient Care
4 Chapter 4: Patient & Site Preparation (Domain 2B — 13 items)
4.1 Patient Identification Standards 4.2 Requisition Review, Order Clarification & Documentation 4.3 Physiological Factors & Basal State Patient Prep 4.4 Patient Education & Therapeutic Communication 4.5 Venous Site Selection & Prohibited Sites 4.6 Antiseptic Selection & Tourniquet Application
5 Chapter 5: Routine Venipuncture Procedure (Domain 3 — 30%)
5.1 Prioritizing Collections: STAT, Timed & Routine 5.2 Routine Venipuncture: Preparation & Patient Assessment 5.3 Needle Insertion, Collection & Post-Puncture Care 5.4 CLSI Order of Draw & Tube Additive Mechanics 5.5 Fill Volumes, Inversions & Matching Tests to Tubes
6 Chapter 6: Special Patient Populations & Precautions
6.1 Precautions for Patients with Medical Conditions 6.2 Adapting Collection for Pediatric Patients 6.3 Geriatric, Dialysis & Other Difficult-Draw Populations
7 Chapter 7: Capillary & Special Collections
7.1 Capillary Blood Composition, Indications & Contraindications 7.2 Fingerstick Site Selection, Warming & Technique 7.3 CLSI GP42 Capillary Order of Draw & Blood Gas Collection 7.4 Neonatal Heelstick & Newborn Metabolic Screening 7.5 Blood Culture Collection Protocols & Timing 7.6 Therapeutic Drug Monitoring & Glucose Tolerance Testing 7.7 Point-of-Care Testing Procedures
8 Chapter 8: Specimen Handling, Processing & Non-Blood Specimens
8.1 Specimen Mixing & Mandatory Bedside Labeling 8.2 Assessing Specimen Suitability & Rejection Criteria 8.3 Temperature-, Light- & Time-Sensitive Specimen Handling 8.4 Specimen Processing: Centrifugation, Aliquoting & Storage 8.5 Non-Blood Specimen Collection & Patient Instruction 8.6 Processing Non-Blood Specimens & Routing to Laboratory Departments
9 Chapter 9: Collection Complications & Troubleshooting (Domain 4 — 15%)
9.1 Vasovagal Syncope: Recognition & Emergency Response 9.2 Seizures, Nausea, Petechiae & Allergic Reactions 9.3 Nerve Injury, Hematomas & Accidental Arterial Puncture 9.4 Technical Troubleshooting & the Two-Attempt Rule 9.5 Hemolysis & Hemoconcentration 9.6 IV Contamination & Analytical Interference
10 Chapter 10: Law, Ethics & Regulatory Standards (Domain 5 — 15%)
10.1 Civil Law, Torts, Negligence & Standard of Care 10.2 Patient Consent, the AHA Bill of Rights & Refusal 10.3 HIPAA Privacy Rule & Permitted Disclosures 10.4 Forensic Chain of Custody & Blood Alcohol Collection 10.5 Workplace Safety Regulation: OSHA, SDS, NFPA & Fire Response 10.6 CLIA ’88, Quality Assurance & Quality Control 10.7 Reportable Incidents, Risk Management & Error Disclosure
11 Chapter 11: Comprehensive Review & Clinical Practice Scenarios
11.1 Critical Order of Draw & Additive Reference Summary 11.2 Clinical Decision Scenarios & Troubleshooting Drills 11.3 Exam-Day Strategy & Professional Recertification
8.2 Assessing Specimen Suitability & Rejection Criteria
Key Takeaways Explain This Topic AI
Unlabeled or mislabeled specimens are rejected outright and are never relabeled by the receiving laboratory.
Hemolysis, clotting in an anticoagulated tube, and QNS (quantity not sufficient) are the three most common rejection reasons.
Wrong tube type, expired tube, and exceeded stability time are equally disqualifying even when the specimen looks normal.
Blood must never be poured from one tube into another to correct a short draw, because additives cannot be reconciled.
An irreplaceable specimen such as CSF may be processed under a documented exception with provider notification rather than discarded.
Last updated: August 2026
- 8.2 Assessing Specimen Suitability & Rejection Criteria
- Universal Laboratory Specimen Rejection Criteria
When a specimen fails to meet rigorous pre-analytical quality standards, the clinical laboratory must reject the sample and mandate an immediate redraw. Understanding the clinical etiology and consequences of specimen rejection is vital for every phlebotomist. +===================================================================================================+
- | MASTER SPECIMEN REJECTION MATRIX |
- +===================================================================================================+
- | Rejection Criterion | Root Phlebotomy Cause | Analytical Impact / Clinical Danger | Action |
- +---------------------+-----------------------------+--------------------------------------+--------+
- | Unlabeled / | Labeling away from bedside; | Zero tolerance; potential fatal | REJECT |
- | Mislabeled Tube | failure to verify 2 PPID | transfusion or wrong-patient therapy | Redraw |
- +---------------------+-----------------------------+--------------------------------------+--------+
- | Quantity Not | Difficult draw; vacuum loss;| Inadequate sample for analyzer dead | REJECT |
- | Sufficient (QNS) | premature needle exit | volume; altered anticoagulant ratio | Redraw |
- +---------------------+-----------------------------+--------------------------------------+--------+
- | Gross Hemolysis | Forceful syringe pull; wet | False elevation of K+, LDH, AST, Fe; | REJECT |
- | (Pink/Red Plasma) | alcohol; needle too small | optical interference in spectrophot | Redraw |
- +---------------------+-----------------------------+--------------------------------------+--------+
- | Clotted Anticoag | Failure to invert additive | Platelets/clotting factors trapped; | REJECT |
- | Tube (EDTA/Heparin) | tubes immediately at bedside| false low platelets; clogs analyzer | Redraw |
- +---------------------+-----------------------------+--------------------------------------+--------+
- | Wrong Tube Drawn | Failure to follow requisition| Incompatible additive (e.g. EDTA for | REJECT |
- | | or CLSI order of draw | Ca/K panel destroys assay chemistry) | Redraw |
- +---------------------+-----------------------------+--------------------------------------+--------+
- | Centrifugation | Spinning un-clotted serum | Latent fibrin strands form post-spin;| REJECT |
- | Errors | tubes (<30 min clot time) | plugs analyzer pipetting needles | Redraw |
- +---------------------+-----------------------------+--------------------------------------+--------+
- | Re-Centrifugation | Spinning gel tubes twice to | Trapped RBC potassium leaks across | REJECT |
- | of Gel Tubes | yield extra serum volume | disrupted barrier; false hyperkalemia| Redraw |
- +===================================================================================================+
- Detailed Analysis of Rejection Mechanisms
Unlabeled or Mislabeled Tubes (Zero-Tolerance Policy): Laboratory accreditation standards (CAP, Joint Commission) mandate that an unlabeled or mislabeled specimen can never be rectified, relabeled, or verified retroactively . Even if the phlebotomist claims certainty regarding the specimen's origin, the sample must be completely discarded and redrawn to prevent lethal misidentification errors.
Quantity Not Sufficient (QNS): Occurs when the drawn blood volume is inadequate for the automated analyzer to aspirate its required dead-volume, or when an anticoagulant tube (such as sodium citrate) is underfilled, altering the chemical ratio.
Gross In Vitro Hemolysis: Recognized by a clear pink-to-ruby-red coloration in centrifuged serum or plasma resulting from ruptured erythrocytes. Hemolysis causes catastrophic false elevations in intracellular analytes (potassium, LDH, AST, magnesium, phosphorus) and interferes with optical spectrophotometric readings of bilirubin and troponin.
Clotted Anticoagulant Specimens: When an EDTA, heparin, or citrate tube is not inverted immediately, the blood begins to clot, trapping platelets and fibrinogen in micro-thrombi. This produces falsely depressed platelet counts on automated CBC analyzers and causes microscopic clots to clog sensitive liquid aspiration probes.
Centrifugation Errors and Latent Fibrin: Standard serum tubes (red plastic, Gold SST) require a minimum of 30 to 60 minutes of unperturbed upright standing to achieve complete clot formation before centrifugation. If a serum tube is centrifuged prematurely (e.g., after 10 minutes), incomplete clotting factors continue to generate gelatinous latent fibrin strands in the separated serum, which foul analyzer aspiration probes and produce erroneous results.
Re-Centrifugation Hazards: Phlebotomists must never re-centrifuge a gel barrier tube (SST or PST) that has already been spun. Re-centrifuging ruptures the established polymer barrier and forces cellular fluid and high-concentration potassium from the packed erythrocytes across the gel into the serum, causing severe artifactual hyperkalemia .
Assessing Suitability Before the Specimen Leaves the Room
DTP task 3.15 is "assess the suitability of a specimen for analysis." The exam frames this as a collector responsibility , not merely a laboratory function — because the collector is the only person who can fix the problem while the patient is still present.
Run a four-point check before you leave:
Volume. Is every tube filled to its required level? A short citrate tube is unusable; a short EDTA distorts hematology indices.
Appearance. Is any tube visibly hemolyzed (pink to red plasma or serum), lipemic (milky), or icteric? Hemolysis discovered at the bedside can be re-drawn immediately.
Clots. Gently examine anticoagulated tubes. Visible fibrin strands or clots in a lavender tube mean the CBC will be rejected.
Labels. Two identifiers, date, time, and your initials — verified against the patient, not against the requisition alone.
Standard Rejection Criteria
Rejection reason Typical cause Preventable at the bedside?
Unlabeled or mislabeled Labeling away from the patient; transposed labels on a multi-patient round Yes — entirely
Hemolyzed Small-gauge needle, wet alcohol, vigorous shaking, prolonged tourniquet, forceful syringe transfer Mostly
- Clotted (anticoagulant tubes) Failure to invert immediately, slow or interrupted draw Yes
- QNS — quantity not sufficient Short draw, failed vacuum, poor flow Yes
- Wrong tube type Not verifying the test-to-tube mapping Yes
- Expired tube Not checking the expiration date before use Yes
- Improper handling Missed chilling, missed light protection, delayed delivery Yes
- Contaminated with IV fluid Drawing above an infusing line or from the same arm Yes
- Exceeded stability window Specimen held too long before separation or analysis Usually
Warning
Never pour blood from one tube into another. A common improvisation is combining two short lavender tubes into one. This is prohibited: the additive concentration cannot be reconciled, the anticoagulant-to-blood ratio is destroyed, and any tube already containing a clot activator or gel contaminates the receiving tube. A short draw is recollected, not consolidated.
The Irreplaceable-Specimen Exception
Laboratories maintain a documented exception process for specimens that cannot be recollected without harm or that are impossible to obtain again — cerebrospinal fluid, an intraoperative specimen, or a timed specimen from a completed protocol. In those cases the laboratory may process the specimen while documenting the deficiency, notifying the ordering provider, and flagging the limitation on the released report . This is an exception granted by the laboratory, never a decision the collector makes unilaterally, and it never applies to a mislabeled specimen where patient identity itself is in doubt.
Reporting Your Own Errors
If you realize after the fact that you may have mislabeled or mishandled a specimen, report it immediately . A recollection ordered ten minutes later costs a venipuncture; a wrong result acted on clinically can cost far more. Concealing a suspected labeling error is both an ethical violation and, in most facilities, a terminable offense.